VNUS Medical Technologies, Inc. Sustainability Profile
VNUS Medical Technologies, Inc., a prominent player in the medical device industry, is headquartered in the United States. Founded in the early 2000s, the company has established itself as a leader in innovative solutions for the treatment of venous diseases, particularly through its advanced endovenous laser therapy (EVLT) systems. With a focus on minimally invasive procedures, VNUS offers unique products that enhance patient outcomes and streamline clinical workflows. The company has achieved significant milestones, including the development of proprietary technologies that set it apart in the competitive landscape. Recognised for its commitment to quality and innovation, VNUS Medical Technologies continues to expand its operational reach, serving healthcare professionals across major regions in the US and beyond. Its dedication to advancing venous health solutions solidifies its position as a trusted name in the industry.
DitchCarbon Score
How does VNUS Medical Technologies, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
VNUS Medical Technologies, Inc.'s score of 50 is higher than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
VNUS Medical Technologies, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Medtronic plc, and as such, it inherits emissions data and climate commitments from its parent organisation. As part of its climate strategy, VNUS Medical Technologies aligns with the sustainability initiatives set forth by Medtronic plc. This includes participation in various climate-related frameworks such as the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), both of which are cascaded from Medtronic. However, specific reduction targets or achievements for VNUS Medical Technologies have not been disclosed. While no absolute emissions figures are provided, VNUS Medical Technologies is committed to addressing climate change through the broader goals established by Medtronic plc, which may include significant reductions in greenhouse gas emissions across their operations. The company is expected to contribute to these initiatives as part of its corporate responsibility and sustainability efforts.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 74,992,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 |
| Scope 2 | 269,008,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | 000,000,000 | 000,000,000 | - |
How Carbon Intensive is VNUS Medical Technologies, Inc.'s Industry?
How Carbon Intensive is VNUS Medical Technologies, Inc.'s Location?
VNUS Medical Technologies, Inc.'s Scope 3 Categories Breakdown
VNUS Medical Technologies, Inc.'s Scope 3 emissions, which increased by 48% last year and increased by approximately 48% since 2021, demonstrating supply chain emissions tracking. Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 55% of total emissions under the GHG Protocol, with "Downstream Transportation & Distribution" being the largest emissions source at 47% of Scope 3 emissions.
Top Scope 3 Categories
VNUS Medical Technologies, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
VNUS Medical Technologies, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
